NeoPharm CO., LTD. (092730.KQ)

KRW 11960.0

(-0.33%)

Total Assets Summary of NeoPharm CO., LTD.

NeoPharm CO., LTD.'s latest annual total assets in 2023 was 179.33 Billion KRW , up 15.44% from previous year.
NeoPharm CO., LTD.'s latest quarterly total assets in 2024 Q1 was 185.29 Billion KRW , up 3.32% from previous quarter.
NeoPharm CO., LTD. reported annual total assets of 155.34 Billion KRW in 2022, up 8.33% from previous year.
NeoPharm CO., LTD. reported annual total assets of 143.4 Billion KRW in 2021, up 7.84% from previous year.
NeoPharm CO., LTD. reported quarterly total assets of 185.29 Billion KRW for 2024 Q1, up 3.32% from previous quarter.
NeoPharm CO., LTD. reported quarterly total assets of 162.28 Billion KRW for 2023 Q1, up 4.47% from previous quarter.

Annual Total Assets Chart of NeoPharm CO., LTD. (2023 - 2012)

Historical Annual Total Assets of NeoPharm CO., LTD. (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	179.33 Billion KRW	15.44%
2022	155.34 Billion KRW	8.33%
2021	143.4 Billion KRW	7.84%
2020	132.97 Billion KRW	8.34%
2019	122.74 Billion KRW	68.3%
2018	72.92 Billion KRW	28.63%
2017	56.69 Billion KRW	21.9%
2016	46.5 Billion KRW	15.09%
2015	40.4 Billion KRW	0.0%
2012	34.14 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	183.75 Billion KRW	-0.83%
2024 Q1	185.29 Billion KRW	3.32%
2023 Q1	162.28 Billion KRW	4.47%
2023 FY	179.33 Billion KRW	15.44%
2023 Q4	179.33 Billion KRW	5.95%
2023 Q3	169.26 Billion KRW	4.67%
2023 Q2	161.71 Billion KRW	-0.35%
2022 Q3	149.08 Billion KRW	1.02%
2022 Q1	148.92 Billion KRW	3.85%
2022 FY	155.34 Billion KRW	8.33%
2022 Q4	155.34 Billion KRW	4.2%
2022 Q2	147.57 Billion KRW	-0.9%
2021 Q4	143.4 Billion KRW	1.47%
2021 Q1	141.12 Billion KRW	6.12%
2021 FY	143.4 Billion KRW	7.84%
2021 Q2	138.73 Billion KRW	-1.69%
2021 Q3	141.32 Billion KRW	1.87%
2020 FY	132.97 Billion KRW	8.34%
2020 Q4	132.97 Billion KRW	5.44%
2020 Q2	125.03 Billion KRW	-2.07%
2020 Q3	126.11 Billion KRW	0.86%
2020 Q1	127.68 Billion KRW	4.02%
2019 Q3	111.35 Billion KRW	2.9%
2019 Q1	74.55 Billion KRW	2.22%
2019 FY	122.74 Billion KRW	68.3%
2019 Q4	122.74 Billion KRW	10.23%
2019 Q2	108.21 Billion KRW	45.16%
2018 Q2	60.91 Billion KRW	1.11%
2018 FY	72.92 Billion KRW	28.63%
2018 Q1	60.24 Billion KRW	6.26%
2018 Q4	72.92 Billion KRW	13.99%
2018 Q3	63.97 Billion KRW	5.03%
2017 Q1	47.73 Billion KRW	2.63%
2017 FY	56.69 Billion KRW	21.9%
2017 Q4	56.69 Billion KRW	11.16%
2017 Q3	51 Billion KRW	5.44%
2017 Q2	48.37 Billion KRW	1.35%
2016 Q2	40.49 Billion KRW	0.0%
2016 Q4	46.5 Billion KRW	10.38%
2016 Q3	42.13 Billion KRW	4.05%
2016 Q1	- KRW	-100.0%
2016 FY	46.5 Billion KRW	15.09%
2015 Q4	40.4 Billion KRW	0.0%
2015 FY	40.4 Billion KRW	0.0%
2013 Q2	35.26 Billion KRW	2.78%
2013 Q3	33.38 Billion KRW	-5.33%
2013 Q1	34.31 Billion KRW	0.51%
2012 Q4	34.14 Billion KRW	0.0%
2012 FY	34.14 Billion KRW	0.0%

Peer Total Assets Comparison of NeoPharm CO., LTD.

Name	Total Assets	Total Assets Difference
Kolmar BNH Co., Ltd.	694.5 Billion KRW	74.178%